|
|
|
|
|
|
|
|
|
|
|
01.04.26 - 14:03
|
Janux Therapeutics Announces Development Candidate Nomination Under Bristol Myers Squibb Collaboration, Triggering $35 Million Milestone Payment (Business Wire)
|
|
|
SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies, today announced the nomination of a development candidate under its collaboration and exclusive worldwide license agreement with Bristol Myers Squibb. The milestone was achieved following the identification of a tumor-activated therapeutic, utilizing Janux's TRACTr platform, targeting an undisclosed solid tumor antigen expressed across several human cancer types, triggering a $35 million milestone payment to Janux.
“This milestone underscores the strength of our approach to generating value through both internal innovation and strategic partnerships, and reflects the continued promise of our tumor-activated platforms,” said David Campbell, Ph.D., President and Chief Executive Officer of Janux. “The nomination of a development candidate highlights our ability to translate platform insights into differentiated therapeutics in col...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.03.26 - 14:12
|
These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity (24/7 Wall St.)
|
|
|
A death cross forms when a stock's 50-day moving average crosses below its 200-day moving average, signaling a potential downtrend. Right now, Bristol Myers Squibb (NYSE: BMY), FedEx (NYSE: FDX), and Ralph Lauren (NYSE: RL) are all flashing that signal. With the CBOE Volatility Index (VIX) at around 25, elevated macro uncertainty is clustering these ... These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity
The post These 3 Stocks Trigger Bearish Signals but 2 Offer Hidden Opportunity appeared first on 24/7 Wall St.....
|
|
|
19.03.26 - 12:00
|
Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026 (Business Wire)
|
|
|
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) will announce results for the first quarter of 2026 on Thursday, April 30, 2026. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET.
Investors and the general public are invited to listen to a live audio webcast of the call at http://investor.bms.com. Materials related to the call will be available on the company's Investor Relations website prior to the start of the conference call.
A replay of the webcast will be available here approximately three hours after the conference call concludes.
About Bristol Myers Squibb: Transforming Patients' Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and fo...
|
|
|
19.03.26 - 11:21
|
Evotec: Positive News verpuffen – Aktie fällt erneut (Der Aktionaer)
|
|
|
Auch eigentlich gute Meldungen prallen bei der Aktie von Evotec derzeit einfach ab. Beim Wirkstoffforscher Evotec klingelt die Kasse: Das Unternehmen erhält erneut eine Meilensteinzahlung vom US-Pharmakonzern Bristol Myers Squibb (BMS). Die Aktie verliert trotzdem heute erneut mehr als drei Prozent....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
